High intensity exercise programme in patients with hypertrophic cardiomyopathy: a randomized trial
Open Access
- 3 March 2025
- journal article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 46 (19) , 1803-1815
Abstract
Background and Aims: The feasibility and impact of high intensity exercise programmes in patients with hypertrophic cardiomyopathy (HCM) are unknown. This study was conducted to determine the feasibility of a high intensity exercise programme and explore safety and efficacy outcomes in patients with HCM. Methods: Participants were randomized to a 12-week supervised exercise programme (n = 40) in addition to usual care, or usual care alone (n = 40). All participants underwent assessment at baseline and 12 weeks. The exercise group was re-evaluated 6 months post-programme. Feasibility was assessed by (i) recruitment, adherence, and retention rates; (ii) staffing ratios; (iii) logistics; and (iv) acceptability of the intervention. The primary exploratory safety outcome was a composite of arrhythmia-related events. Exploratory secondary outcomes included changes in (i) cardiorespiratory fitness; (ii) cardiovascular risk factors; and (iii) quality of life, anxiety, and depression scores. Results: Overall, 67 (84%) participants completed the study (n = 34 and n = 33 in the exercise and usual care groups, respectively). Reasons for non-adherence included travel, work, and family commitments. Resource provision complied with national cardiac rehabilitation standards. There was no difference between groups for the exploratory safety outcome (P = .99). At 12 weeks, the exercise group had a greater increase in peak oxygen consumption (VO2) [+4.1 mL/kg/min, 95% confidence interval (CI) 1.1, 7.1] and VO2 at anaerobic threshold (+2.3 mL/kg/min, 95% CI 0.4, 4.1), lower systolic blood pressure (−7.3 mmHg, 95% CI −11.7, −2.8) and body mass index (−0.8 kg/m2, 95% CI −1.1, −0.4), and greater improvement in hospital anxiety (−3, 95% CI −4.3, −1.7) and depression (−1.7, 95% CI −2.9, −0.5) scores, compared to the usual care group. Most exercise gains dissipated at 6 months. Conclusions: A high intensity exercise programme is feasible in patients with HCM, with apparent cardiovascular and psychological benefits, and no increase in arrhythmias. A large-scale study is required to substantiate findings and assess long-term safety of high intensity exercise in HCM.Keywords
Funding Information
- Cardiac Risk in the Young (1050845)
This publication has 46 references indexed in Scilit:
- Vigorous Exercise in Patients With Hypertrophic CardiomyopathyJAMA Cardiology, 2023
- Development of the Hypertrophic Cardiomyopathy Symptom Questionnaire (HCMSQ): A New Patient-Reported Outcome (PRO) InstrumentPharmacoEconomics - Open, 2022
- Association of Obesity With Adverse Long-term Outcomes in Hypertrophic CardiomyopathyJAMA Cardiology, 2020
- Effect of Moderate-Intensity Exercise Training on Peak Oxygen Consumption in Patients With Hypertrophic CardiomyopathyJAMA, 2017
- Usefulness of 14-Day Holter for Detection of Nonsustained Ventricular Tachycardia in Patients With Hypertrophic CardiomyopathyThe American Journal of Cardiology, 2016
- Predictors of long-term outcomes in patients with hypertrophic cardiomyopathy undergoing cardiopulmonary stress testing and echocardiographyAmerican Heart Journal, 2015
- Physical Activity and Other Health Behaviors in Adults With Hypertrophic CardiomyopathyThe American Journal of Cardiology, 2013
- Hypertrophic cardiomyopathy: an important global diseaseThe American Journal of Medicine, 2004
- Primary Prevention of HypertensionClinical and Public Health Advisory From the National High Blood Pressure Education ProgramJAMA, 2002
- Clinical Course of Hypertrophic Cardiomyopathy in a Regional United States CohortJAMA, 1999